Evidence map›Paper›PMID 39749649›Full record

ArticleAnnals of medicine2025

Comparative retrospective analysis of cord blood transplantation with ATG-containing conditioning regimens and haploidentical stem cell transplantation: similar survival outcomes with reduced incidence of GVHD.

Yongjia Liu, Zeyin Liang, Hanyun Ren, Yujun Dong, Wei Liu, Yue Yin, Bingjie Wang, Qingyun Wang, Qingya Wang, Yuan Li

Abstract readComparative Study
In one paragraph

Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yongjia LiuDepartment of Hematology, Peking University First Hospital, Beijing, China.
Zeyin LiangDepartment of Hematology, Peking University First Hospital, Beijing, China.
Hanyun RenDepartment of Hematology, Peking University First Hospital, Beijing, China.
Yujun DongDepartment of Hematology, Peking University First Hospital, Beijing, China.
Wei LiuDepartment of Hematology, Peking University First Hospital, Beijing, China.
Yue YinDepartment of Hematology, Peking University First Hospital, Beijing, China.
Bingjie WangDepartment of Hematology, Peking University First Hospital, Beijing, China.ORCID 0000-0003-4426-5863
Qingyun WangDepartment of Hematology, Peking University First Hospital, Beijing, China.
Qingya WangDepartment of Hematology, Peking University First Hospital, Beijing, China.
Yuan LiDepartment of Hematology, Peking University First Hospital, Beijing, China.ORCID 0000-0002-5392-9871

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCord blood (CB) is widely used in treating haematologic disorders due to its broad availability, tolerance to significant histocompatibility antigen disparities, and low incidence of chronic graft-versus-host disease (cGVHD). The cord blood transplantation (CBT) with anti-thymocyte globulin (ATG)-containing conditioning regimens shows promise in this regard.

methodsWe conducted a retrospective review of data from patients who underwent CBT at our centre from August 2003 to December 2022. Patients undergoing CBT with ATG were matched with those who received HLA-haploidentical haematopoietic stem cell transplantation (haplo-HSCT). Propensity score matching (PSM) was utilized to form 105 matched pairs (140 patients) for comprehensive trial analysis.

resultsThe cumulative incidence of neutrophil and platelet engraftment was significantly lower in the CBT group. Patients in the CBT group exhibited significantly lower incidences of grade II-IV acute GVHD (aGVHD) and cGVHD compared to the haplo-HSCT group (8.57% vs. 29.52%,

conclusionOur single-centre retrospective long-term follow-up investigations indicated that although the implantation rate of CBT is lower than that of haplo-HSCT, patients undergoing CBT with ATG-containing conditioning regimens may have a comparable overall survival with a lower risk of GVHD compared to those undergoing haplo-HSCT.

Indexed as

Antilymphocyte SerumCord Blood Stem Cell TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation ConditioningAdolescentAdultChildChild, PreschoolFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesTransplantation, HaploidenticalAntilymphocyte Serumanti-thymocyte globulinCord blood transplantationgraft-versus-host diseaseHLA-haploidentical haematopoietic stem cell transplantationoverall survival

Identifiers

PMID39749649
PMCPMC11703471

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.